Q2 2025 Earnings Conference Call August 12, 2025 5:00 AM ETCompany ParticipantsBen Kohn - CEO, President & DirectorMarc B.

Theravance Biopharma, Inc. ( NASDAQ: TBPH) Q2 2025 Earnings Conference Call August 12, 2025 5:00 PM ET Aine Miller - Senior VP of Development & Head of Ireland Office Aziz Sawaf - Senior VP & CFO ...

Operator: Good afternoon, and welcome to Diodes Incorporated Second Quarter 2025 Financial Results Conference Call.

HCI Group, Inc. (NYSE: HCI) Q2 2025 Earnings Call Transcript August 9, 2025 ...

Q2 2025 Earnings Call Transcript August 9, 2025 Operator: Welcome to the Curtiss-Wright Corporation Second Quarter 2025 ...

Gevo Inc (GEVO) reports robust earnings with significant growth in adjusted EBITDA and strategic advancements in carbon credits and renewable projects.

Archer Aviation Inc (ACHR) reports a strong financial position with $1.7 billion in liquidity, while navigating FAA ...

Maintained over 50 million MAUs for the eighth consecutive quarter, MAUs exceeded the post-midterm election Q2 2023 level ...

Cash Gross Margin-- 38.4% cash gross margin in Q2 2025, also within guidance and historical range of the last five years.

Assured Guaranty (AGO) reported Q2 financial results, with a call discussing new business, credit outlooks, market conditions ...

Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q2 2025 Earnings Conference Call. [Operator ...

Glucagon injection salesdeclined 25% to $20.6 million in Q2 2025, driven by increased competition and a market shift toward ...